New insights into the development of lymphoid tissues

Serge A. van de Pavert,Reina E. Mebius
DOI: https://doi.org/10.1038/nri2832
IF: 108.555
2010-08-13
Nature Reviews Immunology
Abstract:Key PointsThe earliest event in lymph node development is the initial clustering of lymphoid-tissue inducer (LTi) cells at the location where lymph nodes will form. Attraction to this location is regulated by expression of CXC-chemokine ligand 13 (CXCL13). Recent studies suggest that this might be induced by retinoic acid produced by nearby nerve fibres.Both lymph node and Peyer's patch development require the induction of lymphotoxin-α1β2 (LTα1β2) expression by LTi cells, which enables them to interact with lymphotoxin-β receptor (LTβR) expressed by stromal organizer cells. Signalling through LTβR on stromal organizer cells leads to the expression of chemokines, adhesion molecules and cytokines that are required for the attraction, retention and survival of haematopoietic cells in the developing lymphoid tissue.The formation of mucosal-associated lymphoid tissues differs from the formation of lymph nodes and Peyer's patches. For nasopharynx-associated lymphoid tissues, the homeostatic chemokines are not needed, whereas for tear duct-associated lymphoid tissue LTi cells are not necessary, and both can form independently of LTβR signalling.During chronic inflammation tertiary lymphoid structures form directly at the site of inflammation. When they develop in response to a viral infection they contribute to the production of antiviral immunity and can be viewed as beneficial for the host. By contrast, those that develop in autoimmune diseases may support the activation of autoreactive cells.
immunology
What problem does this paper attempt to address?